快而精医药(QGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

QGEN 快而精医药

已收盘 10-23 16:00:00 EDT

50.39

+0.17

+0.34%

盘后50.39

+0.000.00%

19:30 EDT

最高50.45	最低50.33	成交量714.44万
今开50.38	昨收50.22	日振幅0.24%
总市值103.80亿	流通市值103.67亿	总股本2.06亿
成交额3.60亿	换手率3.47%	流通股本2.06亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"QGEN","market":"US","secType":"STK","nameCN":"快而精医药","latestPrice":50.39,"timestamp":1792785600000,"preClose":50.22,"halted":0,"volume":7144401,"hourTrading":{"tag":"盘后","latestPrice":50.39,"preClose":50.39,"latestTime":"19:30 EDT","volume":9327,"amount":469985.055,"timestamp":1792798205126,"change":0,"changeRate":0,"amplitude":0.000397},"delay":0,"changeRate":0.003385105535643204,"floatShares":205741367,"shares":205998950,"eps":1.966724,"marketStatus":"已收盘","change":0.17,"latestTime":"10-23 16:00:00 EDT","open":50.38,"high":50.445,"low":50.325,"amount":360032500.608858,"amplitude":0.002389,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.966724,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1793001600000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":50.22,"dividendRate":0.007208,"preHourTrading":{"tag":"盘前","latestPrice":50.37,"preClose":50.22,"latestTime":"09:29 EDT","volume":432419,"amount":21789573.518726002,"timestamp":1792762199999,"change":0.15,"changeRate":0.002987,"amplitude":0.003982},"postHourTrading":{"tag":"盘后","latestPrice":50.39,"preClose":50.39,"latestTime":"19:30 EDT","volume":9327,"amount":469985.055,"timestamp":1792798205126,"change":0,"changeRate":0,"amplitude":0.000397},"volumeRatio":0.528084,"impliedVol":0.1019,"impliedVolPercentile":0.016},"requestUrl":"/m/hq/s/QGEN/wiki","defaultTab":"wiki","newsList":[{"id":"2677965091","title":"欧洲分子检测龙头Qiagen(QGEN.US)接受EQT收购要约：每股46.50欧元，较7月股价溢价40.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677965091","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677965091?lang=zh_cn&edition=full","pubTime":"2026-10-22 21:13","pubTimestamp":1792674784,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，Qiagen周四表示，已同意接受私募股权公司殷拓集团发出的全现金公开收购要约，该交易对这家欧洲分子检测公司的估值约为108亿欧元。盘前交易时段，Qiagen股价上涨近1%。赛默飞世尔最初于2020年3月宣布以每股39欧元收购Qiagen，后在机构投资者因价格问题表示反对后提高了报价。本周早些时候，Qiagen还披露了第三季度初步营收数据，净销售额达5.48亿美元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1511101.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["EUO","QGEN","LU2125909247.SGD","LU1923622614.USD","NBIE","MNA","LU2433249047.HKD","BK4121","MRGR","MEURmain","EURmain","LU2125909593.SGD","FXE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677617598","title":"传EQT提议以超50美元/股收购快而精医药(QGEN.US) KKR亦参与竞购","url":"https://stock-news.laohu8.com/highlight/detail?id=2677617598","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677617598?lang=zh_cn&edition=full","pubTime":"2026-10-21 07:26","pubTimestamp":1792538799,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2125909593.SGD","LU1923622614.USD","LU2125909247.SGD","UUP","LU2433249047.HKD","QGEN","BK4121","UDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136074613","title":"快而精医药任命乔纳森·M·普拉特为新任CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=1136074613","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136074613?lang=zh_cn&edition=full","pubTime":"2026-08-24 21:57","pubTimestamp":1787579858,"startTime":"0","endTime":"0","summary":"路透社8月24日电——快而精医药（QIAGEN N.V.）发布公告，公司董事会正式任命乔纳森·M·普拉特为首席执行官。这一任命自2026年9月1日起正式生效。\n据悉，在定于2026年第四季度召开的临时股东大会上，普拉特还将被提名为公司常务董事，届时需经股东大会表决批准。\n与此同时，现任首席执行官蒂埃里·贝尔纳将卸任CEO及常务董事职务。不过，为确保权力平稳过渡，贝尔纳将继续留任至今年年底，协助公司完成交接工作。\n值得注意的是，尽管管理层迎来变动，快而精医药仍重申其对2026年第三季度及全年的业绩展望保持不变。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2433249047.HKD","QGEN","LU2125909593.SGD","LU1923622614.USD","LU2125909247.SGD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198182224","title":"快而精医药第二季度调整后每股收益0.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1198182224","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198182224?lang=zh_cn&edition=full","pubTime":"2026-08-06 04:26","pubTimestamp":1785961568,"startTime":"0","endTime":"0","summary":"8月5日，快而精医药（Qiagen NV）公布了第二季度财报数据。数据显示，该公司第二季度每股收益为0.5美元。调整后的每股收益则达到0.62美元，超出市场预期。这一财务表现反映了公司在关键业务领域的持续增长与成本控制成效。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2125909593.SGD","LU2125909247.SGD","LU1923622614.USD","BK4121","LU2433249047.HKD","QGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175379412","title":"异动解读｜快而精医药盘中上涨12.83%，多家私募巨头传出收购意向","url":"https://stock-news.laohu8.com/highlight/detail?id=1175379412","media":"行情直击","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175379412?lang=zh_cn&edition=full","pubTime":"2026-07-09 23:00","pubTimestamp":1783609235,"startTime":"0","endTime":"0","summary":"7月9日，快而精医药盘中上涨12.83%，报42.875美元/股，成交额2.88亿美元。消息面上，据彭博报道，私募股权巨头EQT、Advent及KKR已对快而精医药表达初步收购兴趣。事实上，早在今年1月，市场即传出快而精医药正考虑包括出售在内的多种战略选项，当时股价已因此消息一度跳涨逾10%。快而精医药是全球领先的\"样本到洞察\"解决方案提供商，在分子诊断及生命科学领域为超过50万客户提供服务，产品覆盖100多个国家。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122080761","title":"快而精医药支持邦迪布焦埃博拉病毒疫情研究与监测工作","url":"https://stock-news.laohu8.com/highlight/detail?id=1122080761","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122080761?lang=zh_cn&edition=full","pubTime":"2026-05-29 04:20","pubTimestamp":1779999657,"startTime":"0","endTime":"0","summary":"快而精医药宣布，为支持当前邦迪布焦型埃博拉病毒疫情的研究与监测工作，公司已推出两款专门定制的、仅供研究使用的QIAcuity数字PCR检测试剂。这些试剂旨在靶向与本次疫情相关的邦迪布焦埃博拉病毒基因序列。公司强调，该检测试剂仅用于研究目的，不适用于诊断程序。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1923622614.USD","LU2433249047.HKD","LU2125909247.SGD","QGEN","LU2125909593.SGD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512174796","title":"Baird：下调Qiagen(QGEN.US)评级，由优于大市调整至中性评级, 目标价由52.00美元调整至42.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2512174796","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512174796?lang=zh_cn&edition=full","pubTime":"2025-02-19 18:13","pubTimestamp":1739960009,"startTime":"0","endTime":"0","summary":"Baird：下调Qiagen(QGEN.US)评级，由优于大市调整至中性评级, 目标价由52.00美元调整至42.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/19181348262789.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["QGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510051839","title":"快而精医药2024财年实现净利润83.59百万美元，同比减少75.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510051839","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510051839?lang=zh_cn&edition=full","pubTime":"2025-02-09 00:00","pubTimestamp":1739030450,"startTime":"0","endTime":"0","summary":"2月9日，快而精医药公布财报，公告显示公司2024财年净利润为83.59百万美元，同比减少75.49%；其中营业收入为19.78亿美元，同比增加0.66%，每股基本收益为--。从资产负债表来看，快而精医药总负债21.22亿美元，其中短期债务53.48百万美元，资产负债比为2.69，流动比率为3.61。机构评级：截至2025年2月9日，当前有18家机构对快而精医药目标价做出预测，其中目标均价为50.36美元，其中最低目标价为45.00美元，最高目标价为55.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250209000058a23e5b6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250209000058a23e5b6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501222235","title":"大摩：下调Qiagen评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2501222235","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501222235?lang=zh_cn&edition=full","pubTime":"2025-01-06 20:17","pubTimestamp":1736165833,"startTime":"0","endTime":"0","summary":"大摩：下调Qiagen(QGEN.US)评级，由增持调整至持股观望评级,目标价由50.00美元调整至48.00美元。快而精医药(QGEN.US)公司简介：QIAGEN NV是一家控股公司，致力于提供从样品到洞察的解决方案，使客户能够从包含生命构建块的样品中获得有价值的分子见解。该公司的样品技术从血液、组织和其他材料中分离和处理DNA、RNA和蛋白质。牢固的分析技术使这些生物分子可见并准备好进行分析。它的生物信息学软件和知识库解释数据，以报告相关的、可操作的见解。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106202540aba06b52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106202540aba06b52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2490042168","title":"快而精医药盘中异动 快速上涨5.08%报46.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490042168","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2490042168?lang=zh_cn&edition=full","pubTime":"2024-12-11 02:41","pubTimestamp":1733856064,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日02时41分，快而精医药股票出现波动，股价快速拉升5.08%。截至发稿，该股报46.57美元/股，成交量73.3585万股，换手率0.33%，振幅2.41%。快而精医药股票所在的生命科学行业中，整体涨幅为0.27%。其相关个股中，Inotiv, Inc.、快而精医药、Neogenomics, Inc.涨幅较大，Applied Dna Sciences, Inc.、Inotiv, Inc.、Mainz Biomed N.V.较为活跃，换手率分别为8.30%、6.95%、2.66%，振幅较大的相关个股有Inotiv, Inc.、Applied Dna Sciences, Inc.、Mainz Biomed N.V.，振幅分别为23.03%、16.30%、15.61%。Qiagen 近 90% 的收入来自消耗品，其余收入来自仪器和相关服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211024104984b1841&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211024104984b1841&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1923622614.USD","LU2125909593.SGD","LU2433249047.HKD","BK4121","QGEN","LU2125909247.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2483309434","title":"快而精医药2024财年第三财季实现净利润98.06百万美元，同比增加26.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483309434","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2483309434?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686425,"startTime":"0","endTime":"0","summary":"11月16日，快而精医药公布财报，公告显示公司2024财年第三财季净利润为98.06百万美元，同比增加26.01%；其中营业收入为5.02亿美元，同比增加5.46%，每股基本收益为0.44美元。从资产负债表来看，快而精医药总负债27.40亿美元，其中短期债务5.55亿美元，资产负债比为2.29，流动比率为2.18。机构评级：截至2024年11月16日，当前有18家机构对快而精医药目标价做出预测，其中目标均价为51.47美元，其中最低目标价为45.00美元，最高目标价为60.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000130abc51401&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000130abc51401&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QGEN"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.qiagen.com","stockEarnings":[{"period":"1week","weight":0.0877},{"period":"1month","weight":0.1495},{"period":"3month","weight":0.2139},{"period":"6month","weight":0.3075},{"period":"1year","weight":-0.0183},{"period":"ytd","weight":0.0609}],"compareEarnings":[{"period":"1week","weight":-0.0101},{"period":"1month","weight":-0.0122},{"period":"3month","weight":0.0339},{"period":"6month","weight":0.0701},{"period":"1year","weight":0.144},{"period":"ytd","weight":0.1203}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Qiagen N.V.是一家成立于1984年的荷兰控股公司，其子公司是样品检验与化验技术（Sample and Assay Technologies）的主要提供者。该公司是“样本到洞察”解决方案的全球领导者，为两个广泛的客户群中的500,000多个客户提供服务：分子诊断（人类保健）和生命科学（学术界，制药研发和工业应用，主要是法医学）。公司在超过100个国家经营其产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.466667,"avgChangeRate":0.026288},{"month":2,"riseRate":0.6,"avgChangeRate":0.026915},{"month":3,"riseRate":0.366667,"avgChangeRate":0.003481},{"month":4,"riseRate":0.566667,"avgChangeRate":0.013697},{"month":5,"riseRate":0.533333,"avgChangeRate":0.020842},{"month":6,"riseRate":0.533333,"avgChangeRate":0.007096},{"month":7,"riseRate":0.645161,"avgChangeRate":0.038834},{"month":8,"riseRate":0.354839,"avgChangeRate":-0.004238},{"month":9,"riseRate":0.387097,"avgChangeRate":-0.00985},{"month":10,"riseRate":0.451613,"avgChangeRate":0.021975},{"month":11,"riseRate":0.6,"avgChangeRate":0.034255},{"month":12,"riseRate":0.566667,"avgChangeRate":-0.000367}],"exchange":"NYSE","name":"快而精医药","nameEN":"Qiagen NV"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"快而精医药(QGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供快而精医药(QGEN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"快而精医药,QGEN,快而精医药股票,快而精医药股票老虎,快而精医药股票老虎国际,快而精医药行情,快而精医药股票行情,快而精医药股价,快而精医药股市,快而精医药股票价格,快而精医药股票交易,快而精医药股票购买,快而精医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"快而精医药(QGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供快而精医药(QGEN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}